ScoreWhy is Brooks Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 2.42%
- Poor long term growth as Net Sales has grown by an annual rate of 4.36% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.69
2
With ROE of 12.1, it has a Expensive valuation with a 2.6 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -26.44%, its profits have risen by 170.3% ; the PEG ratio of the company is 0.1
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -26.44% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Brooks Lab. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Brooks Lab.
-26.44%
-0.47
55.71%
Sensex
4.75%
0.40
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.36%
EBIT Growth (5y)
24.94%
EBIT to Interest (avg)
-3.69
Debt to EBITDA (avg)
3.19
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
0.83
Tax Ratio
1.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.39%
ROCE (avg)
-11.80%
ROE (avg)
2.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
34
Price to Book Value
2.57
EV to EBIT
42.04
EV to EBITDA
34.61
EV to Capital Employed
2.48
EV to Sales
3.27
PEG Ratio
0.13
Dividend Yield
NA
ROCE (Latest)
5.90%
ROE (Latest)
12.08%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
OPERATING CF(Y)
Highest at Rs 2.63 Cr
PBT LESS OI(Q)
At Rs 7.59 cr has Grown at 2563.2% (vs previous 4Q average
NET SALES(Latest six months)
At Rs 48.96 cr has Grown at 26.45%
PAT(Latest six months)
Higher at Rs 17.56 cr
ROCE(HY)
Highest at 12.36%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Brooks Lab.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 7.59 cr has Grown at 2563.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 0.29 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 7.98 cr has Grown at 1472.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 0.51 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 2.63 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Latest six months
At Rs 48.96 cr has Grown at 26.45%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
